| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Business Officer +1 more
3 companies
Henderson Michael Thomas is a Chief Executive Officer at APGE with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $121.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $27.37 | $273,740.73 | -1.9% | |
| Jul 1, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $30.97 | $309,701.26 | -1.3% | |
| Jun 8, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sell | 606 | $30.01 | $18,185.25 | -0.1% | |
| Jun 3, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sell | 784 | $30.04 | $23,548.54 | -0.3% | |
| Jun 1, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sell | 2,585 | $29.37 | $75,911.65 | -0.5% | |
| May 5, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 1,460 | $30.47 | $44,493.35 | -0.9% | |
| May 4, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 3,905 | $29.52 | $115,266.78 | -0.8% | |
| Apr 1, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 2,585 | $26.94 | $69,629.23 | -0.5% | |
| Mar 2, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 3,975 | $32.44 | $128,965.21 | -1.1% | |
| Feb 3, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 3,975 | $34.90 | $138,729.49 | -2.2% |